Home » Topics » BioWorld

BioWorld
RSS

Pharma Clinical & FDA Action Update: October 2013

Nov. 11, 2013

Non-U.S. Clinical Trials & Regulatory Actions: October 2013

Nov. 11, 2013

Phase III Clinical Trials Update: October 2013

Nov. 11, 2013

European Cancer Congress in Amsterdam: October 2013

Nov. 11, 2013

AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference: October 2013

Nov. 11, 2013

American College of Rheumatology: October 2013

Nov. 11, 2013

Phase I Clinical Trials Update: October 2013

Nov. 11, 2013

Phase II Clinical Trials Update: October 2013

Nov. 11, 2013

Week in Washington

Nov. 11, 2013

FDA Approvals In October

Nov. 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...